PKCα Promotes Generation of Reactive Oxygen Species Via DUOX2 in Hepatocellular Carcinoma.

Jiajun Wang,Miaomiao Shao,Min Liu,Peike Peng,Lili Li,Weicheng Wu,Lan Wang,Fangfang Duan,Mingming Zhang,Shushu Song,Dongwei Jia,Yuanyuan Ruan,Jianxin Gu
DOI: https://doi.org/10.1016/j.bbrc.2015.06.021
2015-01-01
Abstract:Hepatocellular carcinoma (HCC) remains the second leading cause of cancer-related death worldwide, and elevated rates of reactive oxygen species (ROS) have long been considered as a hallmark of almost all types of cancer including HCC. Protein kinase C alpha (PKCα), a serine/threonine kinase among conventional PKC family, is recognized as a major player in signal transduction and tumor progression. Overexpression of PKCα is commonly observed in human HCC and associated with its poor prognosis. However, how PKCα is involved in hepatocellular carcinogenesis remains not fully understood. In this study, we found that among the members of conventional PKC family, PKCα, but not PKCβI or βII, promoted ROS production in HCC cells. PKCα stimulated generation of ROS by up-regulating DUOX2 at post-transcriptional level. Depletion of DUOX2 abrogated PKCα-induced activation of AKT/MAPK pathways as well as cell proliferation, migration and invasion in HCC cells. Moreover, the expression of DUOX2 and PKCα was well positively correlated in both HCC cell lines and patient samples. Collectively, our findings demonstrate that PKCα plays a critical role in HCC development by inducing DUOX2 expression and ROS generation, and propose a strategy to target PKCα/DUOX2 as a potential adjuvant therapy for HCC treatment.
What problem does this paper attempt to address?